| Neuralstem Swinging For The ALS Fences Seeking Alpha Lou Gehrig's Disease is the colloquial name for Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that inhibits proper messaging between the brain and muscles, eventually leading to complete paralysis in those who suffer from it. See all stories on this topic » |
| Cytokinetics Announces Opening of BENEFIT-ALS, A Phase IIb Clinical Trial of ... MarketWatch (press release) BENEFIT-ALS is a Phase IIb, multi-national, double-blind, randomized, placebo-controlled, clinical trial designed to evaluate the safety, tolerability and potential efficacy of tirasemtiv (formerly CK-2017357) in patients with amyotrophic lateral ... See all stories on this topic » |
No comments:
Post a Comment